TFF Pharmaceuticals, Inc. (TFFP)

TFF Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.21	5.48	16.61	33.79	35.3	28.09
Cash & Cash Equivalents	3.21	5.48	16.61	33.79	35.3	28.09
Cash Growth	-73.71%	-67.02%	-50.84%	-4.27%	25.65%	173.79%
Receivables	0	0	0	1.63	0	0
Other Current Assets	1.65	2.11	2.41	3.41	2.26	1.09
Total Current Assets	4.86	7.59	19.03	38.84	37.56	29.19
Property, Plant & Equipment	1.98	2.12	3.27	1.86	1.1	0
Long-Term Investments	2.34	2.31	1.81	0	0	0
Other Long-Term Assets	0.01	0.01	0.01	0	0	0
Total Long-Term Assets	4.32	4.44	5.1	1.86	1.1	0
Total Assets	9.19	12.03	24.12	40.7	38.66	29.19
Accounts Payable	1.66	0.96	0.92	1.49	1.3	0.41
Deferred Revenue	0.14	0.1	0.13	0.05	0.02	0
Current Debt	0.08	0.08	0.08	0	0	0
Other Current Liabilities	1.98	1.29	0	0.42	0	0
Total Current Liabilities	3.87	2.43	1.13	1.96	1.32	0.41
Long-Term Debt	0.01	0.03	0.11	0	0	0
Other Long-Term Liabilities	0	0	0	0	0	1.13
Total Long-Term Liabilities	0.01	0.03	0.11	0	0	1.13
Total Liabilities	3.88	2.46	1.24	1.96	1.32	1.54
Total Debt	0.1	0.12	0.19	0	0	0
Debt Growth	-44.98%	-39.57%	-	-	-	-
Retained Earnings	-124.07	-118.33	-97.09	-65.32	-34.28	-15.71
Comprehensive Income	-0.2	-0.15	-0.14	-0.05	-0.05	0
Shareholders' Equity	5.3	9.57	22.88	38.74	37.34	27.64
Net Cash / Debt	3.12	5.36	16.42	33.79	35.3	28.09
Net Cash / Debt Growth	-74.12%	-67.34%	-51.41%	-4.27%	25.65%	173.79%
Net Cash Per Share	1.31	2.99	13.69	34.04	43.21	101.72
Working Capital	0.99	5.16	17.89	36.88	36.24	28.78
Book Value Per Share	2.22	5.34	19.08	39.02	45.70	100.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).